CY1123864T1 - Νεα παραγωγα αμινο-ιμιδαζοπυριδινης σαν αναστολεις κινασης janus και φαρμακευτικες χρησεις - Google Patents
Νεα παραγωγα αμινο-ιμιδαζοπυριδινης σαν αναστολεις κινασης janus και φαρμακευτικες χρησειςInfo
- Publication number
- CY1123864T1 CY1123864T1 CY20211100085T CY211100085T CY1123864T1 CY 1123864 T1 CY1123864 T1 CY 1123864T1 CY 20211100085 T CY20211100085 T CY 20211100085T CY 211100085 T CY211100085 T CY 211100085T CY 1123864 T1 CY1123864 T1 CY 1123864T1
- Authority
- CY
- Cyprus
- Prior art keywords
- kinase inhibitors
- janus kinase
- pharmaceutical uses
- novel amino
- imidazopyridine derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pulmonology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Η παρούσα εφεύρεση αναφέρεται σε μια ένωση σύμφωνα με τον τύπο (Ι) ή φαρμακευτικά αποδεκτά άλατα, ένυδρα άλατα ή διαλύματα της, όπου R1 είναι C1-αλκύλιο, R2 είναι C1-αλκύλιο, R3 είναι C2-αλκύλιο, R4 είναι υδρογόνο, R5 είναι υδρογόνο. Η εφεύρεση αναφέρεται ακόμη στις αναφερόμενες ενώσεις για χρήση στη θεραπεία, σε φαρμακευτικές συνθέσεις που περιλαμβάνουν τις αναφερόμενες ενώσεις, στις αναφερόμενες ενώσεις για χρήση στη θεραπεία αυτοάνοσων ασθενειών και σε ενδιάμεσα προϊόντα για την παρασκευή των αναφερόμενων ενώσεων.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP17151020 | 2017-01-11 | ||
PCT/EP2018/050548 WO2018130563A1 (en) | 2017-01-11 | 2018-01-10 | Novel amino-imidazopyridine derivatives as janus kinase inhibitors and pharmaceutical use thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1123864T1 true CY1123864T1 (el) | 2022-05-27 |
Family
ID=57777557
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20211100085T CY1123864T1 (el) | 2017-01-11 | 2021-02-01 | Νεα παραγωγα αμινο-ιμιδαζοπυριδινης σαν αναστολεις κινασης janus και φαρμακευτικες χρησεις |
Country Status (26)
Country | Link |
---|---|
US (1) | US10703751B2 (el) |
EP (1) | EP3568396B1 (el) |
JP (1) | JP7009504B2 (el) |
KR (1) | KR102548543B1 (el) |
CN (1) | CN110167938A (el) |
AU (1) | AU2018208516B2 (el) |
BR (1) | BR112019014191A2 (el) |
CA (1) | CA3045567A1 (el) |
CY (1) | CY1123864T1 (el) |
DK (1) | DK3568396T3 (el) |
ES (1) | ES2846741T3 (el) |
HR (1) | HRP20210095T1 (el) |
HU (1) | HUE052720T2 (el) |
IL (1) | IL267829B (el) |
LT (1) | LT3568396T (el) |
MX (1) | MX2019008331A (el) |
MY (1) | MY195576A (el) |
PL (1) | PL3568396T3 (el) |
PT (1) | PT3568396T (el) |
RS (1) | RS61317B1 (el) |
RU (1) | RU2019125177A (el) |
SI (1) | SI3568396T1 (el) |
TW (1) | TWI760419B (el) |
UA (1) | UA123972C2 (el) |
WO (1) | WO2018130563A1 (el) |
ZA (1) | ZA201904190B (el) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JOP20190144A1 (ar) | 2016-12-16 | 2019-06-16 | Janssen Pharmaceutica Nv | إيميدازو بيرولو بيريدين كمثبطات لعائلة jak الخاصة بإنزيمات الكيناز |
TW202016110A (zh) | 2018-06-15 | 2020-05-01 | 比利時商健生藥品公司 | Jak激酶家族之小分子抑制劑 |
WO2020007698A1 (en) * | 2018-07-06 | 2020-01-09 | Leo Pharma A/S | Novel amino-imidazopyrimidine derivatives as janus kinase inhibitors and pharmaceutical use thereof |
CN114555595B (zh) * | 2019-08-30 | 2023-12-26 | Tsd生命科学有限公司 | 咪唑并吡啶衍生物及将其作为有效成分的药学组合物 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5394404B2 (ja) * | 2008-02-06 | 2014-01-22 | ブリストル−マイヤーズ スクイブ カンパニー | キナーゼ阻害剤として有用な置換イミダゾピリダジン類 |
CA2781578A1 (en) | 2010-01-12 | 2011-07-21 | F. Hoffmann-La Roche Ag | Tricyclic heterocyclic compounds, compositions and methods of use thereof |
CN103168032A (zh) * | 2010-08-05 | 2013-06-19 | 安美基公司 | 抑制间变性淋巴瘤激酶的苯并咪唑和氮杂苯并咪唑化合物 |
EP2518071A1 (en) * | 2011-04-29 | 2012-10-31 | Almirall, S.A. | Imidazopyridine derivatives as PI3K inhibitors |
EP2527344A1 (en) | 2011-05-25 | 2012-11-28 | Almirall, S.A. | Pyridin-2(1H)-one derivatives useful as medicaments for the treatment of myeloproliferative disorders, transplant rejection, immune-mediated and inflammatory diseases |
WO2013007768A1 (en) | 2011-07-13 | 2013-01-17 | F. Hoffmann-La Roche Ag | Tricyclic heterocyclic compounds, compositions and methods of use thereof as jak inhibitors |
WO2013007765A1 (en) | 2011-07-13 | 2013-01-17 | F. Hoffmann-La Roche Ag | Fused tricyclic compounds for use as inhibitors of janus kinases |
UY34615A (es) | 2012-02-10 | 2013-09-30 | Galapagos Nv | Nuevos compuestos útiles para el tratamiento de enfermedades degenerativas e inflamatorias. |
SG10201703533VA (en) | 2012-11-01 | 2017-06-29 | Incyte Corp | Tricyclic fused thiophene derivatives as jak inhibitors |
MX2015006152A (es) * | 2012-11-20 | 2016-01-20 | Genentech Inc | Compuestos de aminopirimidina como inhibidores de mutantes de egfr que contienen t7 9 0m. |
CN104098563A (zh) | 2013-04-02 | 2014-10-15 | 山东亨利医药科技有限责任公司 | Jnk抑制剂化合物 |
TW201625643A (zh) | 2014-04-30 | 2016-07-16 | 英塞特公司 | 製備jak1抑制劑之方法及其新形式 |
PT3509591T (pt) | 2016-10-03 | 2021-12-27 | Highlightll Pharmaceutical Hainan Co Ltd | Novos inibidores seletivos da jak1 e usos dos mesmos |
JOP20190144A1 (ar) | 2016-12-16 | 2019-06-16 | Janssen Pharmaceutica Nv | إيميدازو بيرولو بيريدين كمثبطات لعائلة jak الخاصة بإنزيمات الكيناز |
-
2018
- 2018-01-10 EP EP18702412.0A patent/EP3568396B1/en active Active
- 2018-01-10 KR KR1020197021697A patent/KR102548543B1/ko active IP Right Grant
- 2018-01-10 BR BR112019014191-0A patent/BR112019014191A2/pt active Search and Examination
- 2018-01-10 CA CA3045567A patent/CA3045567A1/en active Pending
- 2018-01-10 PT PT187024120T patent/PT3568396T/pt unknown
- 2018-01-10 WO PCT/EP2018/050548 patent/WO2018130563A1/en unknown
- 2018-01-10 RS RS20210044A patent/RS61317B1/sr unknown
- 2018-01-10 AU AU2018208516A patent/AU2018208516B2/en active Active
- 2018-01-10 JP JP2019557681A patent/JP7009504B2/ja active Active
- 2018-01-10 UA UAA201908568A patent/UA123972C2/uk unknown
- 2018-01-10 DK DK18702412.0T patent/DK3568396T3/da active
- 2018-01-10 PL PL18702412T patent/PL3568396T3/pl unknown
- 2018-01-10 HU HUE18702412A patent/HUE052720T2/hu unknown
- 2018-01-10 US US16/477,249 patent/US10703751B2/en active Active
- 2018-01-10 MX MX2019008331A patent/MX2019008331A/es unknown
- 2018-01-10 RU RU2019125177A patent/RU2019125177A/ru unknown
- 2018-01-10 MY MYPI2019003964A patent/MY195576A/en unknown
- 2018-01-10 CN CN201880006261.0A patent/CN110167938A/zh active Pending
- 2018-01-10 SI SI201830191T patent/SI3568396T1/sl unknown
- 2018-01-10 LT LTEP18702412.0T patent/LT3568396T/lt unknown
- 2018-01-10 ES ES18702412T patent/ES2846741T3/es active Active
- 2018-01-11 TW TW107101035A patent/TWI760419B/zh active
-
2019
- 2019-06-26 ZA ZA2019/04190A patent/ZA201904190B/en unknown
- 2019-07-03 IL IL267829A patent/IL267829B/en unknown
-
2021
- 2021-01-19 HR HRP20210095TT patent/HRP20210095T1/hr unknown
- 2021-02-01 CY CY20211100085T patent/CY1123864T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
JP7009504B2 (ja) | 2022-01-25 |
ES2846741T3 (es) | 2021-07-29 |
ZA201904190B (en) | 2020-10-28 |
WO2018130563A1 (en) | 2018-07-19 |
US10703751B2 (en) | 2020-07-07 |
KR102548543B1 (ko) | 2023-06-29 |
HUE052720T2 (hu) | 2021-05-28 |
DK3568396T3 (da) | 2021-01-18 |
MX2019008331A (es) | 2020-01-14 |
CN110167938A (zh) | 2019-08-23 |
IL267829B (en) | 2022-02-01 |
RU2019125177A (ru) | 2021-02-15 |
EP3568396B1 (en) | 2020-11-11 |
PT3568396T (pt) | 2021-02-09 |
UA123972C2 (uk) | 2021-06-30 |
SI3568396T1 (sl) | 2021-04-30 |
JP2020504186A (ja) | 2020-02-06 |
PL3568396T3 (pl) | 2021-05-31 |
MY195576A (en) | 2023-02-02 |
HRP20210095T1 (hr) | 2021-03-05 |
KR20190103231A (ko) | 2019-09-04 |
LT3568396T (lt) | 2021-02-10 |
IL267829A (en) | 2019-09-26 |
US20190367512A1 (en) | 2019-12-05 |
RU2019125177A3 (el) | 2021-05-11 |
AU2018208516A1 (en) | 2019-07-11 |
AU2018208516B2 (en) | 2021-07-08 |
CA3045567A1 (en) | 2018-07-19 |
EP3568396A1 (en) | 2019-11-20 |
TWI760419B (zh) | 2022-04-11 |
TW201829407A (zh) | 2018-08-16 |
BR112019014191A2 (pt) | 2020-02-11 |
RS61317B1 (sr) | 2021-02-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1123864T1 (el) | Νεα παραγωγα αμινο-ιμιδαζοπυριδινης σαν αναστολεις κινασης janus και φαρμακευτικες χρησεις | |
CY1120104T1 (el) | Αναστολεις της syk | |
CY1118969T1 (el) | Ενωσεις πυριμιδινο-2-αμινης και η χρηση τους ως αναστολεις των κινασων jak | |
CY1122611T1 (el) | Ενωσεις πυραζολοπυριμιδινης ως αναστολεις κινασης | |
CY1120635T1 (el) | Βενζαμιδια αμινοετεροαρυλιου ως αναστολεις κινασης | |
CY1121867T1 (el) | Αναστολεις jak2 και alk2 και μεθοδοι για τη χρηση τους | |
CY1121763T1 (el) | Παραγωγα διπυραζολιου ως αναστολεις jak | |
CY1123627T1 (el) | Παραγωγα διυδροϊμιδαζοπυραζινονης χρησιμα στη θεραπευτικη αντιμετωπιση του καρκινου | |
CY1121357T1 (el) | Νεος ανοσοτροποποιητης και αντιφλεγμονωδεις ενωσεις | |
CY1122610T1 (el) | Αλκοξυ πυραζολια ως ενεργοποιητες διαλυτης γουανυλικης κυκλασης | |
GEP20207105B (en) | 1,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives and 1,1,1-trifluoro-4-hydroxybutan-2yl carbamate derivatives as magl inhibitors | |
CY1117719T1 (el) | Παραγωγα αμινοπυριμιδινης ως διαμορφωτες της lrrk2 | |
CY1117078T1 (el) | Παραγωγα 1-((5-ετεροαρυλθειαζολ-2-υλ) αμινοκαρβονυλ) πυρρολιδινο-2-καρβοξαμιδης ως αναστολεις φωσφατιδυλινοσιτολ 3-κινασης (ρι3κ) χρησιμα στη θεραπεια πολλαπλασιαστικων νοσων | |
CY1120378T1 (el) | Υποκατεστημενα παραγωγα του διφαινυλο βουτανοϊκου φωσφονικου οξεος ως αναστολεις νερ (ουδετερης ενδοπεπτιδασης) | |
CY1117080T1 (el) | Θεραπευτικος παραγοντας για στενωση του σπονδυλικου σωληνα | |
CY1120325T1 (el) | Τρικυκλικες ετεροκυκλικες ενωσεις ως αναστολεις φωσφοϊνοσιτιδιου 3-κινασης | |
EA201650031A1 (ru) | Производные пирролидин-2,5-диона, фармацевтические композиции и способы применения в качестве ингибиторов ido1 | |
UY31940A (es) | Derivados sustituido del 4,5-(sustituido-piridin-3-il)-1-metil-1h-indol, sus sales farmacéuticamente aceptables, polimorfos, rotámeros, pro-fármacos, anantiómeros, hidratos, solvatos del mismo, composiciones conteniéndolos y aplicaciones | |
CY1121677T1 (el) | Ενωσεις διμεθυλοβενζοϊκου οξεος | |
CY1120478T1 (el) | Παραγωγα 2,6-υποκατεστημενης πουρινης και η χρηση αυτων στην αγωγη υπερπλαστικων διαταραχων | |
CY1117122T1 (el) | Παραγωγα πυραζολοσπειροκετονης για χρηση ως αναστολεις ακετyλ-coa καρβοξυλασης | |
CY1122182T1 (el) | Ανοσοκατασταλτικες φαρμακοτεχνικες μορφες | |
PE20151601A1 (es) | Compuestos novedosos de pirimidina y piridina y su uso | |
CO6321276A2 (es) | Derivados de tiazol usados como inhibidores de pi3- cinasa | |
EA202091016A1 (ru) | Пиримидиновое соединение в качестве ингибитора jak киназы |